miR-532-3p promotes hepatocellular carcinoma progression by targeting PTPRT.
Wang Y, Yang Z, Wang L, Sun L, Liu Z, Li Q, Yao B, Chen T, Wang C, Yang W, Liu Q, Han S.
Wang Y, et al. Among authors: chen t.
Biomed Pharmacother. 2019 Jan;109:991-999. doi: 10.1016/j.biopha.2018.10.145. Epub 2018 Nov 5.
Biomed Pharmacother. 2019.
PMID: 30551553
Free article.